Trial NCT01646125

View at ClinicalTrials.gov 
Org. Study IDs: CAUY922A2207
Secondary IDs: 2012-001050-25

Last trial update was posted on 2019-07-24

MeSH Interventions

Docetaxel Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Advanced Non Small Cell Lung Cancer (NSCLC)

Stopping Reasons

An interim analysis was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.

Limitations And Caveats

The data monitoring committee (DMC's) recommendation based on the Interim Analysis (IA) results to terminate the study early due to futility, data was not collected for this assessment on many of the secondary endpoints.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID